{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:32:02Z","timestamp":1769045522838,"version":"3.49.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,28]]},"abstract":"<jats:p>\n                    To examine the relationship between plasma cortisol levels and the severity of white matter hyperintensities (WMH) in patients with major depressive disorder (MDD). This study included 240 patients with MDD who were hospitalized in the Department of Neuropsychology at Hebei General Hospital from January 1, 2023, to December 31, 2024. General data and plasma cortisol concentrations were obtained. Based on the total score of the Fazekas scale, patients were divided into 3 groups: no\/mild group (Fazekas scale total score 0\u20132 points, 87 participants), moderate group (Fazekas scale total score 3\u20134 points, 85 participants), and severe group (Fazekas scale total score 5\u20136 points, 68 participants). The disparities in general and clinical data among various patient groups were compared, and the risk factors for WMH were investigated. Among 3 groups of patients, significant differences were in terms of age (58.23\u2005\u00b1\u20058.64 vs 63.59\u2005\u00b1\u20057.62 vs 67.51\u2005\u00b1\u20057.78), proportion of hypertension (37.90% vs 42.40% vs 67.60%), total cholesterol (4.85\u2005\u00b1\u20051.06 vs 4.95\u2005\u00b1\u20051.12 vs 4.53\u2005\u00b1\u20051.05), low-density lipoprotein (3.00\u2005\u00b1\u20050.70 vs 3.10\u2005\u00b1\u20050.81 vs 2.67\u2005\u00b1\u20050.79), and plasma cortisol level (13.25\u2005\u00b1\u20054.31 vs 14.36\u2005\u00b1\u20054.51 vs 15.86\u2005\u00b1\u20055.06). Age (odds ratio [OR]\u2005=\u20051.10,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.00), hypertension (OR\u2005=\u20051.54,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.03), and cortisol level (OR\u2005=\u20051.09,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.00) were independent risk variables for the severity of WMH in individuals with MDD, while low-density lipoprotein (OR\u2005=\u20050.30,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.04) was a protective factor for the severity of white matter hyperintensity in patients with depression. Plasma cortisol is proposed as an independent risk factor influencing the severity of white matter hyperintensity in individuals with MDD, and ameliorating elevated cortisol levels in these patients may enhance their prognosis.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046196","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:00:36Z","timestamp":1764597636000},"page":"e46196","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Correlation between plasma cortisol and white matter hyperintensity in middle-aged and elderly individuals with major depressive disorder: A cross-sectional study"],"prefix":"10.1097","volume":"104","author":[{"given":"Shipan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Neurology, Hebei Medical University, Shijiazhuang, China"},{"name":"Department of Neurology, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Collaborative Innovation Center for Mechanism and Diagnostics of Neuropsychiatric Diseases, Shijiazhuang, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueru","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Collaborative Innovation Center for Mechanism and Diagnostics of Neuropsychiatric Diseases, Shijiazhuang, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaowei","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hebei General Hospital, Shijiazhuang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Fei","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Collaborative Innovation Center for Mechanism and Diagnostics of Neuropsychiatric Diseases, Shijiazhuang, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyang","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Collaborative Innovation Center for Mechanism and Diagnostics of Neuropsychiatric Diseases, Shijiazhuang, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Collaborative Innovation Center for Mechanism and Diagnostics of Neuropsychiatric Diseases, Shijiazhuang, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyuan","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei Medical University, Shijiazhuang, China"},{"name":"Department of Neurology, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Collaborative Innovation Center for Mechanism and Diagnostics of Neuropsychiatric Diseases, Shijiazhuang, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei Medical University, Shijiazhuang, China"},{"name":"Department of Neurology, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Collaborative Innovation Center for Mechanism and Diagnostics of Neuropsychiatric Diseases, Shijiazhuang, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260121","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41593-020-0621-y","article-title":"Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons.","volume":"23","author":"Nagy","year":"2020","journal-title":"Nat Neurosci"},{"key":"R2-20260121","doi-asserted-by":"crossref","first-page":"e1150","DOI":"10.1038\/tp.2017.108","article-title":"The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning.","volume":"7","author":"Kautzky","year":"2017","journal-title":"Transl Psychiatry"},{"key":"R3-20260121","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/0891988720901783","article-title":"Are apathy and depressive symptoms related to vascular white matter hyperintensities in severe late life depression?","volume":"34","author":"Oudega","year":"2021","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"R4-20260121","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2020.12.016","article-title":"Greater white matter hyperintensities and the association with executive function in suicide attempters with late-life depression.","volume":"103","author":"Lin","year":"2021","journal-title":"Neurobiol Aging"},{"key":"R5-20260121","doi-asserted-by":"crossref","first-page":"e6052","DOI":"10.1002\/gps.6052","article-title":"Association of white matter hyperintensities and clinical vascular burden with depressive symptoms in Black older adults.","volume":"39","author":"Bogoian","year":"2024","journal-title":"Int J Geriatr Psychiatry"},{"key":"R6-20260121","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1038\/npp.2015.158","article-title":"White matter hyperintensity accumulation during treatment of late-life depression.","volume":"40","author":"Khalaf","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"R7-20260121","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jagp.2015.03.001","article-title":"Late-life depression modifies the association between cerebral white matter hyperintensities and functional decline among older adults.","volume":"24","author":"Hybels","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"key":"R8-20260121","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1161\/STROKEAHA.119.027544","article-title":"Common genetic variation indicates separate causes for periventricular and deep white matter hyperintensities.","volume":"51","author":"Armstrong","year":"2020","journal-title":"Stroke"},{"key":"R9-20260121","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2020.19080848","article-title":"Hormonal treatments for major depressive disorder: state of the art.","volume":"177","author":"Dwyer","year":"2020","journal-title":"Am J Psychiatry"},{"key":"R10-20260121","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.psyneuen.2017.05.018","article-title":"Diurnal cortisol slopes and mental and physical health outcomes: a systematic review and meta-analysis.","volume":"83","author":"Adam","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"R11-20260121","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1749-6632.2009.05331.x","article-title":"Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease.","volume":"1186","author":"McEwen","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"R12-20260121","doi-asserted-by":"crossref","first-page":"809684","DOI":"10.3389\/fnagi.2021.809684","article-title":"Serum cortisol is associated with cerebral small vessel disease-related brain changes and cognitive impairment.","volume":"13","author":"Qiu","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"R13-20260121","doi-asserted-by":"crossref","first-page":"001140","DOI":"10.1161\/JAHA.114.001140","article-title":"What are white matter hyperintensities made of? Relevance to vascular cognitive impairment.","volume":"4","author":"Wardlaw","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"R14-20260121","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biopsych.2012.08.024","article-title":"Lacunar infarcts in deep white matter are associated with higher and more fluctuating depressive symptoms during three years follow-up.","volume":"73","author":"Grool","year":"2013","journal-title":"Biol Psychiatry"},{"key":"R15-20260121","doi-asserted-by":"crossref","first-page":"c3666","DOI":"10.1136\/bmj.c3666","article-title":"The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis.","volume":"341","author":"Debette","year":"2010","journal-title":"BMJ"},{"key":"R16-20260121","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/gps.1596","article-title":"Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study.","volume":"21","author":"Krishnan","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"key":"R17-20260121","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/biom11081102","article-title":"Role of white matter hyperintensities and related risk factors in vascular cognitive impairment: a review.","volume":"11","author":"Chen","year":"2021","journal-title":"Biomolecules"},{"key":"R18-20260121","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neurobiolaging.2023.08.007","article-title":"White matter hyperintensity load mediates the relationship between age and cognition.","volume":"132","author":"Busby","year":"2023","journal-title":"Neurobiol Aging"},{"key":"R19-20260121","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1161\/01.STR.0000135226.53499.85","article-title":"Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.","volume":"35","author":"Jeerakathil","year":"2004","journal-title":"Stroke"},{"key":"R20-20260121","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/brain\/aww008","article-title":"White matter hyperintensities and imaging patterns of brain ageing in the general population.","volume":"139","author":"Habes","year":"2016","journal-title":"Brain"},{"key":"R21-20260121","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1212\/WNL.0000000000007654","article-title":"CNS small vessel disease.","volume":"92","author":"Cannistraro","year":"2019","journal-title":"Neurology"},{"key":"R22-20260121","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuroimage.2018.07.049","article-title":"Associations between low circulatory low-density lipoprotein cholesterol level and brain health in non-stroke non-demented subjects.","volume":"181","author":"Chung","year":"2018","journal-title":"Neuroimage"},{"key":"R23-20260121","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/STROKEAHA.109.563502","article-title":"Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke.","volume":"41","author":"Jimenez-Conde","year":"2010","journal-title":"Stroke"},{"key":"R24-20260121","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/mp.2016.120","article-title":"HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.","volume":"22","author":"Keller","year":"2017","journal-title":"Mol Psychiatry"},{"key":"R25-20260121","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/cen.13277","article-title":"Altered spontaneous brain activity in Cushing\u2019s disease: a resting-state functional MRI study.","volume":"86","author":"Jiang","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R26-20260121","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.neubiorev.2008.04.001","article-title":"Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms.","volume":"32","author":"Garc\u00eda-Bueno","year":"2008","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:01:17Z","timestamp":1768993277000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":26,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046196","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"2025-01-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}